Effects of combined exercise on quality of life for colorectal cancer patients undergoing chemotherapy
Effects of Exercise Training on Health-related Quality of Life in Patients With Unresectable Metastatic Colorectal Cancer: A Multi-center Randomized Controlled Trial
This study tests if an 18-week exercise program can improve the quality of life for colorectal cancer patients who are receiving chemotherapy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Rigshospitalet, Denmark Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 4 sites (Copenhagen and 3 other locations) |
| Trial ID | NCT06938971 on ClinicalTrials.gov |
What this trial studies
This trial aims to evaluate the impact of an 18-week structured exercise program on the health-related quality of life of patients with unresectable metastatic colorectal cancer undergoing first-line chemotherapy. Participants will be randomly assigned to either the exercise intervention group or a control group. The study focuses on assessing how physical activity can improve overall well-being during cancer treatment. The exercise regimen includes both resistance and aerobic training tailored to the patients' capabilities.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older scheduled for chemotherapy for unresectable metastatic colorectal cancer.
Not a fit: Patients who are pregnant, have a life expectancy of less than six months, or have contraindications to exercise will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the quality of life for patients undergoing chemotherapy for metastatic colorectal cancer.
How similar studies have performed: Other studies have shown positive outcomes with exercise interventions in cancer patients, suggesting this approach may be beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: \- Adults (≥18 years of age) schduled to undergo first-line chemotherapy for the treatment of metastatic colorectal cancer. Exclusion criteria : * Pregnancy. * A life expectancy of \< 6 months. * Absolute contraindications to maximal exercise, as per the recommendations by the Danish Society of Cardiology. * ECOG (Eastern Cooperative Oncology Group) performance status \> 2. * Inability to understand the Danish or English language. * Engagement in structured moderate-to-high aerobic exercise training for \>30 min \>1 times/week for the past 3 months at the time of inclusion.
Where this trial is running
Copenhagen and 3 other locations
- Centre for Physical Activity Research, Copenhagen Univerisity Hospital - Rigshospitalet — Copenhagen, Denmark (Recruiting)
- Herlev and Gentofte Hospital — Herlev, Denmark (Recruiting)
- North Zealand University Hospital, Hillerød — Hillerød, Denmark (Recruiting)
- Zealand University Hospital, Roskilde — Roskilde, Denmark (Recruiting)
Study contacts
- Study coordinator: Casper Simonsen, Phd
- Email: casper.simonsen@regionh.dk
- Phone: +45 35 45 76 41
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.